Quest Diagnostics
837 hedge funds and large institutions have $15.9B invested in Quest Diagnostics in 2021 Q3 according to their latest regulatory filings, with 93 funds opening new positions, 293 increasing their positions, 285 reducing their positions, and 59 closing their positions.
58% more first-time investments, than exits
New positions opened: 93 | Existing positions closed: 59
6% more capital invested
Capital invested by funds: $14.9B → $15.9B (+$913M)
3% more funds holding
Funds holding: 814 → 837 (+23)
2.53% more ownership
Funds ownership: 87.11% → 89.64% (+2.5%)
3% more repeat investments, than reductions
Existing positions increased: 293 | Existing positions reduced: 285
2% more call options, than puts
Call options by funds: $188M | Put options by funds: $184M
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$118M |
| 2 |
Renaissance Technologies
New York
|
+$114M |
| 3 |
Goldman Sachs
New York
|
+$87.3M |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$66M |
| 5 |
Schroder Investment Management Group
London,
United Kingdom
|
+$55.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Nordea Investment Management
Stockholm,
Sweden
|
-$290M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$117M |
| 3 |
Morgan Stanley
New York
|
-$98.9M |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$91.6M |
| 5 |
Westfield Capital Management
Boston,
Massachusetts
|
-$86.3M |
DGX Hedge Fund Activity: Q3 2021 in Review
837 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Quest Diagnostics (DGX) for Q3 2021, worth a combined $15.9B — up 6.1% from $14.9B a quarter earlier.
Buyers outnumbered sellers: 93 funds opened new DGX positions and 59 closed out — a net gain of 34 holders — while 293 added to existing stakes and 285 trimmed.
The largest buyer was BlackRock, adding an estimated $118M. The largest seller was Nordea Investment Management, cutting an estimated $290M.
- 837 institutional investors held Quest Diagnostics (DGX) as of Q3 2021, up from 814 in Q2 2021.
- Funds reported $15.9B of Quest Diagnostics stock for Q3 2021, up 6.1% quarter-over-quarter.
- 93 funds opened new Quest Diagnostics positions in Q3 2021 and 59 closed out, a net change of +34 holders.
- The largest Quest Diagnostics buyer in Q3 2021 was BlackRock, an estimated $118M added.
- The largest Quest Diagnostics seller in Q3 2021 was Nordea Investment Management, an estimated $290M sold.
Based on aggregated 13F filings for Q3 2021.